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Purpose: This study compared the perioperative and pathologic outcomes between an extralevator abdominoperineal re-
section (APR) in the prone position and a conventional APR.
Methods: Between September 2011 and March 2014, an extralevator APR in the prone position was performed on 13 pa-
tients with rectal cancer and a conventional APR on 26 such patients. Patients’ demographics and perioperative and 
pathologic outcomes were obtained from the colorectal cancer database and electronic medical charts. 
Results: Age and preoperative carcinoembryonic antigen (CEA) level were significantly different between the conven-
tional and the extralevator APR in the prone position (median age, 65 years vs. 55 years [P = 0.001]; median preoperative 
CEA level, 4.94 ng/mL vs. 1.81 ng/mL [P = 0.011]). For perioperative outcomes, 1 (3.8%) intraoperative bowel perforation 
occurred in the conventional APR group and 2 (15.3%) in the extralevator APR group. In the conventional and extraleva-
tor APR groups, 12 (46.2%) and 6 patients (46.2%) had postoperative complications, and 8 (66.7%) and 2 patients (33.4%) 
had major complications (Clavien-Dindo III/IV), respectively. The circumferential resection margin involvement rate was 
higher in the extralevator APR group compared with the conventional APR group (3 of 13 [23.1%] vs. 3 of 26 [11.5%]).
Conclusion: The extralevator APR in the prone position for patients with advanced low rectal cancer has no advantages in 
perioperative and pathologic outcomes over a conventional APR for such patients. However, through early experience 
with a new surgical technique, we identified various reasons for the lack of favorable outcomes and expect sufficient expe-
rience to produce better peri- or postoperative outcomes. 
Keywords: Advanced low rectal cancer; Extralevator abdominoperineal re section; Prone position; Perioperative outcome; 
Pathologic outcome
INTRODUCTION
After the introduction of the total mesorectal excision (TME) as 
the optimal technique for the resection of rectal cancer, oncologic 
and pathologic outcomes in patients with rectal cancer have sig-
nificantly improved [1-4]. In recent years, anal-sphincter-preserv-
ing surgery, in combination with preoperative concurrent chemo-
radiotherapy (CCRT), has become a common treatment for pa-
tients with lower rectal cancer. Traditionally, an abdominoperi-
neal resection (APR) has been regarded as the gold standard for 
that treatment. Nonetheless, the use of a conventional APR to 
treat patients with locally advanced low rectal cancer has not im-
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proved the oncologic outcomes to the same degree as the use of a 
low anterior resection (LAR) has [5, 6]. The main reason an APR 
leads to relatively poor outcomes is the higher rates of a positive 
circumferential resection margin (CRM) and an intraoperative 
bowel perforation. Thus, the extralevator APR in the prone posi-
tion was introduced by Holm et al. [7] to decrease the high likeli-
hood of CRM involvement and perforation. 
The extralevator APR in the prone position has oncological and 
technical advantages. Because the levator muscles are removed 
along with the anal canal and mesorectum en bloc, a more cylin-
drical specimen is created, and the amount of tissue removed 
from around the tumor is sufficient to achieve a free CRM. Also, 
the perineal dissection allows the creation of sufficient space with 
better visualization, decreasing the likelihood of dissecting along 
the wrong surgical plane or perforating the specimen [8]. Perineal 
dissection in the prone position may help decrease the possibility 
of intraoperative perforation because it allows the rectum to be 
prolapsed out after opening the pelvis, giving excellent visualiza-
tion of the plane between the rectum and adjacent organs [7], 
even though the position change itself could have a negative effect 
on the operative field.
There are a variety of opinions on the postoperative and the on-
cologic outcomes of an extralevator APR. Some contend that the 
technique has not shown any advantage in terms of oncologic 
outcomes and is associated with poor postoperative morbidity [9, 
10]. Conversely, others contend that an extralevator APR in the 
prone position has oncologic superiority due to its technical ad-
vantages [7, 8, 11]. Therefore, we aimed to compare the perioper-
ative and the pathologic outcomes of an extralevator APR in the 
prone position with those of a conventional APR at a single insti-
tution. We hypothesized that, compared with a conventional 
APR, the technical advantages of an extralevator APR in the 
prone position would translate into acceptable perioperative out-
comes and oncologic adequacy.
METHODS
Patients 
This was a retrospective study, and informed consent was ob-
tained from all patients before surgery. Between September 2011 
and March 2014, an extralevator APR in the prone position was 
performed on 13 patients with rectal cancer, and a conventional 
APR in the lithotomy position was carried out on 26 such pa-
tients. Eligibility criteria included a pathologically-confirmed rec-
tal adenocarcinoma and patients who had undergone an APR 
(extralevator or conventional) with a curative intent. At our insti-
tution, the indication for using an APR for the treatment of pa-
tients with rectal cancer is a tumor that is still invading the anal 
sphincter muscle in the image finding after preoperative chemo-
radiotherapy or anal incontinence caused by decreased sphincter 
function even though the tumor is located at the mid rectum. Es-
pecially, when the tumor is located at the level of the anorectal 
ring or has invaded more deeply adjacent muscles such as the pu-
borectalis muscle and the external sphincter muscle, an extraleva-
tor APR, instead of a conventional APR, is recommended for 
achieving a free CRM. Preoperative evaluations included physical 
examination, colonoscopy, transrectal ultrasonography, pelvic 
magnetic resonance imaging, and computed tomography of the 
abdomen, pelvis, and chest. Except those who refused it, most pa-
tients underwent preoperative long-course chemoradiotherapy as 
part of a multimodality treatment course. The details of the che-
motherapy regimens and the radiation treatment schedules are 
described elsewhere [12].
Study objective
The primary objective was to evaluate the perioperative outcomes 
of an extralevator APR in the prone position in terms of intraop-
erative (R0 resection, bowel perforation, pelvic lymph node [LN] 
dissection, operative time, and intraoperative bleeding) and post-
operative (postoperative complication and length of stay) out-
comes compared with those of a conventional APR. 
The secondary objective was to compare the pathologic out-
comes of an extralevator APR in the prone position with those of 
a conventional APR. The pathologic outcomes included gross and 
microscopic findings of excised specimens such as tumor size, 
margin length from tumor, CRM involvement, harvested LNs, 
lymphovascular invasion, histologic grade, Mandard grade, and 
pathologic TNM stage (American Joint Committee on Cancer 
[AJCC] 7th edition). 
Surgical procedures for an extralevator APR
All surgeries were performed on the basis of the principles of a 
TME with autonomic nerve preservation. At the root of the infe-
rior mesenteric artery, either low ligation with principal LN re-
trieval or high ligation was performed. The rectum was mobilized 
by sharp dissection, and the visceral pelvic fascia enveloping the 
mesorectum was separated from the parietal fascia overlying the 
pelvic cavity under direct vision. Mesorectal excision was per-
formed only as far as the levator muscle was visible; further dis-
section was not performed. The proximal colon was transected at 
the level of the pelvic floor, and a sigmoidal stoma was created. 
For the perineal approach, the patients were rotated and fixed in 
the prone position. The anus was closed by suturing, and perineal 
dissection of the anal sphincter was performed halfway between 
the anal verge and ischial tuberosity to the level where the ab-
dominal procedure was terminated. While keeping the perineal 
body intact, the levator muscles were sufficiently excised to create 
a negative CRM. The distinguishing difference between an extral-
evator and a conventional APR was that a cylindrical specimen, 
including almost the entire levator muscle, was acquired while 
performing a more extended perineal dissection.
Pathologic examination
CRM involvement was defined as the presence of tumor cells 
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from the outermost margin of the lesion to the proper mesorectal 
fascia or a maximum distance between the tumor and the proper 
rectal fascia of <1 mm. Pathologic analyses were performed by a 
specialized gastrointestinal pathologist, and the pathologic results 
were staged according to the 7th AJCC TNM staging system. Tu-
mor regressive changes of the rectal cancer (e.g., residual cancer 
and fibrosis) in response to chemoradiation were described using 
the Mandard grading system [13].
Data collection
All information, including the characteristics of the patient and 
the tumor and the perioperative and pathologic outcomes, were 
retrospectively collected from the hospital’s colorectal cancer da-
tabase and electronic medical charts. Preoperative carcinoembry-
onic antigen (CEA) level, tumor location, and history of previous 
abdominal surgery were included in the characteristics of the pa-
tient and the tumor. Data on R0 resection and bowel perforation 
were recorded in perioperative outcomes. Resection margin, 
CRM involvement, and pathologic TNM stage (AJCC 7th edi-
tion) were recorded in pathologic outcomes. 
Statistical analysis
Statistical analyses were performed using IBM SPSS Statistics ver. 
20.0 (IBM Co., Armonk, NY, USA). Descriptive data are pre-
sented as median and interquartile ranges (IQRs) for continuous 
variables and as frequencies and percentages for categorical vari-
ables. Mann-Whitney U-test was used to analyze continuous 
variables, and Fisher exact test or linear-by-linear association was 
used for categorical variables. 
RESULTS
Patient and tumor characteristics
Age and preoperative CEA level were significantly different be-
tween the extralevator and the conventional APR groups (median 
age, 65 years vs. 55 years [P = 0.001]; median preoperative CEA 
level, 4.94 ng/mL vs. 1.81 ng/mL [P = 0.011]). Only patients in the 
conventional APR group had a history of previous abdominal 
surgery (7 of 26, 26.9%). Most patients in both groups were 
treated with preoperative chemoradiotherapy in accordance with 
National Comprehensive Cancer Network guidelines for ad-
vanced low rectal cancer (10 of 13 [76.9%] vs. 25 of 26 [96.2%], P 
= 0.099). The sex ratio and distributions of American Society of 
Anesthesiologists scores were not significantly different between 
the groups. The distributions of tumor locations and the surgical 
approaches were also similar (Table 1).
Perioperative outcomes
Intraoperative bowel perforation occurred in 2 patients (15.4%) in 
the extralevator APR group and 1 patient (3.8%) in the conven-
tional APR (2 of 13 [15.4%] vs. 1 of 26 [3.8%], P = 0.253) (Fig. 1) 
and except for these patients, all were treated with a R0 resection. 
The extralevator APR achieved better results than the conventional 
APR in terms of both operative time and intraoperative bleeding 
volume (median operative time [IQR]: 285 minutes [230–399 
minutes] vs. 355 minutes [321–419 minutes], P = 0.074; median 
bleeding volume [IQR]: 300 mL [125–425 mL] vs. 360 mL [188–
808 mL], P = 0.546). The extralevator APR group started a soft 
diet after surgery one day earlier than the conventional APR group. 
The former also had a significantly shorter hospital stay (median 
hospital stay [IQR]: 10 days [7–22 days] vs. 17 days [12–32 days], 
P = 0.016). The postoperative complication rates were similar in 
both groups (6 of 13 [46.2%] and 12 of 26 [46.2%] for extralevator 
and conventional APR, respectively), but the major complication 
rate (Clavien-Dindo grade III/IV), such as intestinal obstruction 
and urine leakage, was greater in the conventional APR group (2 
of 13 [15.6%] vs. 8 of 26 [30.8%], P = 0.321) (Table 2).
Fig. 1. Bowel perforation induced by both advanced rectal cancer itself and surgical dissection on the tumor site: specimen (A) and tumor site 
(B).
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Pathologic outcomes
With regard to pathologic outcomes, both groups had similar re-
sults for tumor progression. The most common histologic grade 
was the moderately differentiated type (extralevator APR group 
vs. conventional APR group: 9 of 13 [69.2%] vs. 22 of 26 [84.6%], 
P = 0.461), and stage II was most frequent ypTNM stage (extrale-
vator APR group vs. conventional APR group: 7 of 13 [53.8%] vs. 
13 of 26 [50%], P = 0.909). The tumor regression achieved by pre-
operative chemoradiotherapy was similar in both groups, but the 
extralevator APR group achieved a slightly better outcome (P = 
0.275). Even though no significant differences were noted between 
the 2 groups, the extralevator APR group acquired a longer lateral 
margin (median [IQR]: 7.5 mm [0.4–13.75 mm] vs. 4.0 mm [1.5–
8.0 mm], P = 0.544), more harvested LNs (median [IQR]: 17 [12–
26] vs. 12 [7–18], P = 0.076), and a lower rate of fewer than 12 
harvested LNs (3 of 13 [23.1%] vs. 12 of 26 [46.2%], P = 0.295) 
than the conventional APR group (Fig. 2). The CRM involvement 
rate was higher in the extralevator APR group compared with the 
conventional APR (3 of 13 [23.1%] vs. 3 of 26 [11.5%], P = 0.380) 
(Table 3). DISCUSSION
Our results show that an extralevator APR in the prone position 
Table 1. Patient and tumor characteristics 
Variable
Extralevator APR 
(n = 13)
Conventional APR 
(n = 26)
P-value
Age (yr) 55 (48–58) 65 (58–76) 0.001
Sex 0.285
   Male : female 9 : 4 14 : 12
Body mass index (kg/m²) 22.5 (19.0–23.5) 21.1 (20–23.5) 0.735
ASA score 0.271
   1 5 (38.5) 9 (34.6)
   2 8 (61.5) 11 (42.3)
   3 - 5 (19.2)
   4 - 1 (3.9)
Previous abdominal 
   surgery, yes
0 (0) 7 (26.9) 0.073
Neoadjuvant CRT 10 (76.9) 25 (96.2) 0.099
Preoperative CEA (ng/mL) 1.81 (1.09–6.50) 4.94 (2.63–41.71) 0.011
Location of tumor (cm) 1.000
   Middle (5.0–10) 1 (7.7) 2 (7.7)
   Lower (<5.0) 12 (92.3) 24 (92.3)
Surgical approach 0.886
   Open 8 (61.5) 16 (61.5)
   Laparoscopy 3 (23.1) 5 (19.3)
   Robotic 2 (15.4) 5 (19.3)
Values are presented as median (interquartile range) or number (%).
APR, abdominoperineal resection; ASA, American Society of Anesthesiologists; 
CRT, chemoradiotherapy; CEA, carcinoembryonic antigen.
Table 2. Perioperative outcomes
Variable
Extralevator APR 
(n = 13)
Conventional APR 
(n = 26)
P-value
R0 resection 10 (76.9) 25 (96.2) 0.099
Intraoperative tumor perforation 2 (15.4) 1 (3.8) 0.253
Pelvic lymph node dissection 2 (15.4) 10 (38.5) 0.269
Operative time (min) 285 (230–399) 355 (321–419) 0.074
Bleeding (mL) 300 (125–425) 360 (188–808) 0.546
Time to soft diet (day) 4 (3–6) 5 (4–6) 0.116
Hospital stay (day) 10 (7–22) 17 (12–32) 0.016
Postoperative complication 6 (46.2) 12 (46.2) 1.000
   Urinary tract infection 2 (15.4) -
   Urinary distension 2 (15.4) 2 (7.7)
   Perineal wound infection 1 (7.7) 3 (11.6)
   Intra-abdominal abscess 1 (7.7) -
   Postoperative ileus - 4 (15.4)
   Urine leak - 2 (7.7)
   Colitis - 1 (3.8)
Clavien-Dindo classification 0.321
   Grade I-II 4 (31.2) 4 (15.4)
   Grade III 2 (15.6) 8 (30.8)
Values are presented as number (%) or median (interquartile range).
APR, abdominoperineal resection.
Fig. 2. Surgical specimens according to operative method. (A) In the 
extralevator abdominoperineal resection, the levator muscle was left 
attached to the mesorectum, which created a cylindrical specimen. 
(B) In the conventional abdominoperineal resection, a waist was cre-
ated on the specimen.
A B
Annals of
Coloproctology
www.coloproctol.org16
Short-term Outcomes of an Extralevator Abdominoperineal Resection in the Prone Position Compared 
With a Conventional Abdominoperineal Resection for Advanced Low Rectal Cancer: The Early 
Experience at a Single Institution
Seungwan Park, et al.
is feasible and that, compared with a conventional APR, the peri-
operative and pathologic outcomes were acceptable. The median 
operation time in the extralevator APR group was similar to that 
reported at other institutions [10, 14], but the median operation 
time was shorter than that for conventional APR in our early ex-
perience despite the extra position rotation time. Also, the median 
intraoperative bleeding volume was less in the extralevator APR 
group. These results were affected by various factors such as the 
tumor’s characteristics (adjacent organ invasion) and the surgeon’s 
view of the operative field during pelvic dissection. Other studies 
also reported that an APR in the prone position resulted in a 
shorter operation time and less blood loss due to excellent expo-
sure of the operative field [15, 16]. An extralevator APR in the 
prone position is associated with a low tumor perforation rate 
compared to a conventional APR (tumor perforation rate: 8.2% 
vs. 28.2, P < 0.001) [14] because it provides surgeons with a better 
pelvic structure visualization [17]. However, in our early experi-
ence, the rate of intraoperative tumor perforation was higher for 
an extralevator APR than it was for a conventional APR. After re-
viewing cases with intraoperative tumor perforation, we observed 
that the rotated operative field, which was not familiar to the sur-
geon, played an important role in intraoperative tumor perfora-
tion, even though advanced tumors also affected that outcome. 
The prone position during the perineal phase provided a wider 
and better operative field; nevertheless, surgeons with limited ex-
perience with an APR in the prone position encountered diffi-
culty during the perineal dissection because achieving the correct 
surgical plane in an upside-down operative field, especially when 
bulky tumors break the surgical plane, was difficult. De Campos-
Lobato et al. [18] demonstrated that prone or lithotomy position-
ing during the perineal phase of an extralevator APR did not af-
fect perioperative morbidity or oncologic outcomes such as tumor 
perforation, CRM involvement, survival, or recurrence. The au-
thors pointed out that if it is possible to successfully transect the 
levator muscle through a transabdominal approach, the surgeon 
has no need to change patient’s position. Indeed, Chi et al. [19] 
and Zhang et al. [20] described a transabdominal levator transec-
tion via a laparoscopic approach and argued that an extralevator 
APR was feasible without position change. We plan to identify 
which position, prone or lithotomy, is more convenient for sur-
geons during the perineal phase and adapt it while continuously 
enhancing our experience with the extralevator APR.
The present study did include some postoperative complicated 
cases that required reoperation under general anesthesia (Clavien-
Dindo class IIIb), including perineal wound infection resulting in 
dehiscence, urine leakage caused by intraoperative injury, and in-
testinal obstruction. An increased risk of perineal wound infec-
tion, resulting in increased morbidity, has been considered the 
main disadvantage of an extralevator APR [9, 14]. The rate of 
Table 3. Pathologic outcomes
Variable
Extralevator APR 
(n = 13)
Conventional APR 
(n = 26)
P-value
Tumor diameter (cm) 3.00 (1.25–4.00) 3.00 (1.28–5.00) 0.929
Histologic grade 0.461
   Well 2 (15.4) 2 (7.7)
   Moderately 9 (69.2) 22 (84.6)
   Poorly 0 (0) 1 (3.8)
   Mucinous 2 (15.4) 1 (3.8)
ypTNM stage 0.909
   PCR 0 (0) 2 (7.7)
   Stage I 3 (23.1) 5 (19.2)
   Stage II 7 (53.8) 13 (50.0)
   Stage III 3 (23.1) 2 (7.7)
   Stage IV 0 (0) 4 (15.4)
Mandard grade 0.275
   I 1 (7.7) 2 (7.7)
   II 5 (38.5) 5 (19.2)
   III 3 (23.1) 10 (38.5)
   IV 2 (15.4) 6 (23.1)
   V 0 (0) 1 (3.8)
   Unknown 2 (15.4) 2 (7.7)
Distal resection margin (cm) 4.75 (4.00–5.00) 4.5 (3.25–6.25) 0.643
Lateral margin (mm) 7.5 (0.4–13.75) 4 (1.5–8.0) 0.554
CRM involvement 3 (23.1) 3 (11.6) 0.380
LVI invasion 2 (15.4) 4 (15.4) 1.000
Harvested LNs (n) 17 (12–26) 12 (7–18) 0.076
<12 Nodes harvested 3 (23.1) 12 (46.2) 0.295
Values are presented as median (interquartile range) or number (%).
APR, abdominoperineal resection; PCR, pathologic complete response; CRM, cir-
cumferential resection margin; LVI, lymphovascular invasion.
Fig. 3. Large perineal wound defect after an extralevator abdomino-
perineal resection.
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perineal wound complication has been reported to range from 
35% to 66%, and radiotherapy has been reported to be a signifi-
cant risk factor [9, 21-23]. Besides, larger perineal wounds (Fig. 3) 
have been reported to increase the possibility of wound infection. 
Therefore, surgeons have used a myocutaneous flap technique to 
close a large perineal defect to reduce the possibility of wound in-
fection, [7, 24, 25]. We did not initially perform a flap reconstruc-
tion to close large perineal defects. To approximate a large defect 
wound without tension, we first designed the perineal incision 
line, considering tension-free wound closure, by approximating 
the bilateral perineal skin; then, we closed the wound layer by 
layer. The benefits of perineal reconstruction remain to be dem-
onstrated, and we should identify the optimal perineal wound 
closure method while continuing to increase our experience with 
the extralevator APR. In the urinary leakage cases, all tumors had 
penetrated the mesorectal fascia and were positioned at least in 
the anterior area of the rectum. As a result, the prostate and the 
urinary tract were partially excised to achieve an R0 resection, 
and urinary leakage occurred despite surgical reconstruction. The 
reason for intestinal obstructions that required reoperation was a 
perineal hernia in all cases. This is a rare complication, but it can 
occur because APR surgery creates an empty space in the pelvic 
floor [26]. Moreover, it has been suggested that laparoscopic-as-
sisted APR may contribute to an increase in perineal hernia for-
mation, possibly because of the production of fewer adhesions 
[27, 28]. After reviewing the operative record of the cases compli-
cated by intestinal obstructions, we determined that these surger-
ies were performed with a laparoscopic or robotic approach. We 
found that although an extralevator APR created a large perineal 
defect, it did not cause intestinal obstruction or perineal hernia; 
this is in contrast with another study that described an increased 
rate of perineal hernias for an extralevator APR compared to a 
conventional APR [29]. We have recently endeavored to reduce 
the perineal-hernia rate with the use of a mesh fixation on the 
pelvic inlet or an omental patch positioned in the pelvis; the re-
sults will be determined after collecting further data on postoper-
ative complications following an APR. The length of hospital stay 
was most strongly influenced by the severity of the postoperative 
complication, and the median length was longer for the conven-
tional APR group compared both to the extralevator APR group 
and to values published previously [9, 11]. The median length of 
hospital stay in the extralevator APR group was similar to those 
reported in earlier studies regardless of the method of approach 
[11, 14, 30, 31]. Consequently, we can conclude that the rate of se-
vere postoperative complications and the longer hospital stay 
were not caused by the surgical technique (extralevator or con-
ventional), but rather were due to tumor’s characteristics or the 
method of approach.
One study comparing extralevator and conventional APRs re-
ported a relatively lower local recurrence rate in the extralevator 
APR group (5-year local recurrence rate: 5% vs. 23%, P = 0.03) 
[32]. They concluded that this was attributable to the effort to in-
crease the amount of resected specimen containing the anal canal, 
levators, and complete mesorectum. With regard to the patho-
logic outcomes of previous studies, the CRM involvement rate 
varied from 14.8% to 27.6% with the extralevator resection tech-
nique [8, 14, 32], and these results were favorable compared with 
those for a conventional APR [33]. Conversely, a recent, prospec-
tive, large-volume study found that the extralevator technique and 
tumor stage could be risk factors affecting CRM involvement. 
However, the study had several limitations including selection 
bias, patients in the extralevator group being more likely to have 
received neoadjuvant chemoradiation therapy, and a tendency to-
ward a higher tumor stage in the extralevator group [34]. In our 
study, the CRM involvement rate was higher in the extralevator 
APR group. In the cases involving CRM, the tumor was aggra-
vated with invasion of the mesorectal fascia or adjacent organs. 
Increasing tumor stage and fixed tumor have previously been 
shown to increase the risk of CRM involvement [35, 36]. Tumor 
characteristics, including increased T-stage and postradiation fi-
brotic change, as well as inexperience with the extralevator APR 
technique, might play an important role in CRM involvement. 
Even though the amount of tissue removed around the tumor was 
increased by using the extralevator plane, locally advanced tu-
mors that did not regress after CCRT were difficult to excise com-
pletely. In addition, fibrotic tumor changes after CCRT made the 
tumor margin unclear, and a microscopic residual tumor re-
mained among the fibrotic tissue, even though the surgeon had 
grossly confirmed a radial free margin intraoperatively. 
CCRT is now a well-established treatment for patients with lo-
cally advanced lower rectal cancer and is associated with a favor-
able oncologic outcome. As APRs were performed in patients 
with advanced lower rectal cancer, most had undergone preoper-
ative CCRT. According to the Mandard grade (tumor regression 
grade), which could reflect the effect of CCRT, the extralevator 
APR group had slightly better results than the conventional APR 
group. Even though we did not analyze long-term oncologic out-
comes, we expect the improved Mandard grade to influence long-
term oncologic outcome because it predicts long-term outcome 
following preoperative chemoradiation therapy in patients with 
locally advanced rectal cancer [37-39].
This study has some limitations. First, it included a relatively 
small number of subjects and used a nonparametric comparative 
design. Therefore, the evaluation of statistically significant differ-
ences between the 2 groups was restricted. Second, this was an 
early analysis at a single institution, and the data were collected 
retrospectively. Third, we did not assess the long-term outcomes, 
including oncologic results. Despite these shortcomings, this is 
the first study to compare an extralevator APR in the prone posi-
tion with a conventional APR in the lithotomy position in Korea. 
Moreover, we showed various short-term results after an extrale-
vator APR, which is not commonly performed in this country.
In conclusion, compared with a conventional APR, we did not 
acquire better perioperative and pathologic outcomes by per-
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forming an extralevator APR in the prone position for patients 
with advanced low rectal cancer. For several reasons, these results 
were different from those in previous studies. First, we did not 
have enough experience to adapt a new surgical technique of per-
forming a radical excision according to the extralevator plane. 
Second, after changing the patients to the prone position, the sur-
geons had to perform the perineal procedure in an unfamiliar po-
sition and occasionally had difficulty orienting themselves in the 
surgical field. Third, advanced tumor invasion into adjacent or-
gans affected the results because it made resection of a sufficient 
specimen without tumor perforation difficult. We expect better 
perioperative or postoperative outcomes to be achieved after suf-
ficient experience with the procedure. Further large cohort stud-
ies should be carried out to verify the oncologic benefit and safety 
of the extralevator APR in the prone position before its wide-
spread implementation.
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